Atypical hemolytic uremic syndrome (HUS) is clinically difficult to distinguish from HUS and thrombotic thrombocytopenic purpura. Atypical HUS results from dysregulation of complement activation causing thrombotic microangiopathy affecting multiple organ systems. Atypical HUS is associated with high morbidity and mortality, making early recognition and appropriate therapy necessary to improve patient outcomes.
|Original language||English (US)|
|Number of pages||4|
|Journal||JAAPA : official journal of the American Academy of Physician Assistants|
|State||Published - Nov 1 2016|
ASJC Scopus subject areas
- Nurse Assisting